![]() |
市场调查报告书
商品编码
1383495
2030 年医疗设备市场预测:按产品类型、应用、最终用户和地区分類的全球分析Medical Device Market Forecasts to 2030 - Global Analysis By Product Type, Application, End User and By Geography |
根据Stratistics MRC预测,2023年全球医疗设备市场规模将达5,526亿美元,预计2030年将达到9,410亿美元,预测期内年复合成长率为7.9%。
设计用于识别、减轻、监测、治疗或预防疾病或损伤的仪器、机器、植入和体外试剂称为医疗设备。医疗设备具有广泛的用途和复杂程度,但它们对医疗保健至关重要,因为它们有助于诊断和治疗疾病。製造商、零售商和法规机构都在医疗设备领域开展国际业务,这是一项全球性业务。
根据 IDF 发布的 2022 年统计数据,2021 年加拿大约有 290 万人患有糖尿病。此外,根据同一消息来源,预计这一数字到 2030 年将达到 320 万,到 2045 年将达到 340 万。
医疗设备市场受到慢性病发病率上升的严重影响。慢性病通常需要持续的照护和监测,例如糖尿病、呼吸系统疾病、心血管疾病和一些癌症。此外,持续监测的需求导致了远端患者监测技术的技术进步。因此,医疗保健提供者可以透过具有蓝牙和网路存取等连接特性的医疗设备远端监控患者。
昂贵的医疗设备可能会对医疗保健财政造成压力,尤其是在公共资助的系统中。此外,对于医院和其他医疗机构来说,购买和维护先进技术的成本过高,并影响整体营运预算。这使得门诊和农村诊所等小型医疗机构难以购买昂贵的医疗设备并提供广泛的服务,导致医疗服务提供有限,这可能会造成差距并阻碍市场成长。
对血糖仪、穿戴式健身追踪器和血压计等家庭监测设备的需求正在迅速增长,这些小工具使人们无需经常去医疗机构即可掌握自己的健康问题,并且可以进行管理。因此,由于家庭医疗设备的需求,科技正在不断发展。为了改善患者的整体体验,製造商正在开发具有直觉使用者介面、连接性和远端监控功能的设备。家用数位体温计和远端医疗平台是实现远距医疗咨询、推动市场成长的设备的主要范例。
法规调整预计将增加提供患者服务和开发新产品的成本。这些与消费者保密相关的进步包括欧盟 (EU) 实施《一般资料保护规范》(GDPR) 和对设备核准的修订。美国FDA正在寻求更多的临床证据来支持内视镜工具等医疗设备的安全性和有效性主张,导致过去年度来完成上市核准流程所需的时间有所延长。由于设备发布延迟而造成的收益损失以及严格的法规流程可能导致的成本增加将影响对创新设备的投资并影响医疗设备市场的成长。
COVID-19大流行对全球医疗设备市场产生了各种影响。世界各地冠状病毒诊断的意外增加增加了对医疗设备的需求,包括呼吸设备、人工呼吸器、口罩、个人防护设备包等。此外,在 COVID-19 爆发期间,远端医疗和远端患者监护等数位医疗技术的使用急剧增加。医疗设备市场目前正以更快的速度扩张。然而,在 COVID-19 疫情高峰期,所有非必要手术都被搁置,优先考虑择期手术治疗。这对製造必要外科手术医疗设备的公司产生了负面影响。
由于心血管疾病盛行率的增加、知名行业参与者的战术性倡议以及心臟病设备的技术进步等多种原因,预计心臟病设备行业将出现良好的增长。此外,患有肥胖、糖尿病、高血压和高胆固醇的人往往寿命更长,并且更有可能出现心臟问题,因此这些条件也推动了对心臟医疗设备的需求。此外,由于业务扩张和技术进步(例如在心臟穿戴装置中使用人工智慧),越来越多的患者正在使用心臟病设备进行管理,治疗和监测结果正在显着改善,正在推动市场成长。
由于医疗保健专业人员在诊断中心进行测试和治疗以诊断、追踪和治疗疾病,因此诊断中心细分市场预计将在预测期内出现最高的年复合成长率年增长率。诊断设施中使用的医疗设备有多种用途。诊断中心采用最先进的医疗设备,以提高诊断的准确性、速度和效率。此外,它还支持疾病的早期诊断、追踪和客製化治疗计划。诊断中心提供优质医疗保健服务的能力不断受到快速变化的诊断技术领域的影响。
预计北美在预测期内将占据最大的市场占有率。在预测期内,由于慢性病盛行率上升、医疗成本高昂以及领先公司的存在等因素,预计北美将引领医疗设备市场。此外,由于普通人群中急性呼吸症候群等呼吸系统疾病和心血管心臟疾病和中风等慢性疾病的患病率不断上升,心肺体外迴圈手术的增加,对医疗设备的需求也在增加。 。 我是。因此,随着企业专注于创造尖端产品,并采取联盟、收购等多样化的商业策略来维持自己的市场地位,市场正在不断扩大,这就是我开始做的结果。
由于人口高龄化、人均收入增加和人们健康意识增强等因素,亚太地区在预测期内成长最快。此外,该地区医疗基础设施投资的增加预计也将促进医疗设备市场的成长。中国和印度是亚太地区的主要国家,以销售额计算,分别位居全球市场第二和第五名。在这些国家,医疗改革和地方政府的奖励在很大程度上控制着医疗设备产业。
According to Stratistics MRC, the Global Medical Device Market is accounted for $552.6 billion in 2023 and is expected to reach $941.0 billion by 2030 growing at a CAGR of 7.9% during the forecast period. An equipment, machine, implant, or in vitro reagent designed to be used in the identification, mitigation, monitoring, treatment, or prevention of illness or damage is referred to as a medical device. Medical devices come in a wide range of applications and levels of sophistication, but they are all vital to healthcare since they help with diagnosis and treatment of medical disorders. Manufacturers, retailers, and regulatory agencies all operate internationally in the medical device sector, which is a worldwide business.
According to 2022 statistics published by IDF, about 2.9 million people were living with diabetes in Canada in 2021. In addition, as per the same source, this number is projected to reach 3.2 million and 3.4 million by 2030 and 2045, respectively.
The market for medical devices is significantly impacted by the growing incidence of chronic illnesses. Chronic illnesses frequently call for ongoing care and observation, including diabetes, respiratory conditions, cardiovascular diseases, and some forms of cancer. Additionally, remote patient monitoring technologies have advanced technologically due to the requirement for constant monitoring. Thus, healthcare providers can remotely monitor patients to medical gadgets that include connection characteristics like Bluetooth and internet access.
Expensive medical equipment may put a strain on healthcare finances, especially in systems that receive public funding. Moreover, the cost of purchasing and maintaining sophisticated technology can be prohibitive for hospitals and other healthcare institutions, which has an impact on their entire operating budget. Thus expensive medical equipment may be difficult for smaller healthcare institutions, such outpatient clinics or rural clinics, to afford and this makes it more difficult for them to offer a wide range of services, which might result in gaps in the delivery of healthcare thereby hampering the market growth
There has been a surge in demand for home monitoring equipment, including glucometers, wearable fitness trackers, and blood pressure monitors and with the use of these gadgets, people may keep tabs on and take control of their health issues without constantly visiting medical institutions. Thus technology is always evolving due to the need for at-home medical equipment. To improve the entire patient experience, manufacturers are creating devices with intuitive user interfaces, connection features, and remote monitoring capabilities. Digital thermometers for use at home and telehealth platforms have become popular examples of devices that make remote consultations possible thereby propelling the growth of the market.
Regulatory adjustments are expected to lead to higher costs for patient service offerings and the creation of new products. Among these advances related to secrecy of consumption are the General Data Protection Regulation (GDPR), which was put into effect by the European Union, and modifications to device approvals. The US FDA has asked for more clinical evidence to support the security and efficacy claims of medical equipment, such as endoscopic tools, which has resulted in a decreased extension of the time required to complete the marketing authorization process during the last ten years. The potential for missed revenues due to device release delays and higher costs as a result of onerous regulatory processes put pressure on investments in innovative devices, which affect the growth of the market for medical devices.
The COVID-19 pandemic affected the world market for medical equipment in a variety of ways. The unexpected increase in corona virus diagnoses around the globe has increased demand for medical equipment including respiration devices, ventilators, masks, personal protective equipment kits, and other items. Additionally, the use of digital health technologies like telemedicine and remote patient monitoring has increased dramatically during the COVID-19 epidemic. The market for medical equipment is expanding at a faster rate now. However, all non-essential surgical operations were put on hold during the peak days of COVID-19, giving preference to elective surgical treatments. This had a detrimental impact on the firms who make medical devices for necessary surgical procedures.
The cardiology devices segment is estimated to have a lucrative growth, due to many reasons, including the increasing incidence of cardiovascular illnesses, tactical moves by prominent industry players, and advancements in technology in cardiology devices. Furthermore, since more people with obesity, diabetes, hypertension, and high cholesterol live longer lives and are more prone to experience cardiac issues, these conditions are also driving up demand for cardiological medical equipment. Furthermore, an increasing number of patients are being managed with cardiology devices as a result of expanding business operations and technological advancements (such as the use of artificial intelligence in cardiac wearable devices), which has led to exponential therapeutical and monitoring outcomes are driving the growth of the market.
The diagnostic centers segment is anticipated to witness the highest CAGR growth during the forecast period, as healthcare experts conduct tests and treatments in diagnostic centers in order to diagnose, track, and treat illnesses. Diagnostic facilities employ medical equipment for a variety of purposes. Diagnostic accuracy, speed, and efficiency are all improved in diagnostic centers by the incorporation of cutting-edge medical equipment. Additionally, it supports the early diagnosis, tracking, and customized treatment planning of diseases. Diagnostic centers' capacity to deliver high-quality healthcare services is continually shaped by the rapidly changing field of diagnostic technologies.
North America is projected to hold the largest market share during the forecast period owing to the Over the course of the forecast period, North America is anticipated to lead the medical devices market due to factors including the rising prevalence of chronic illnesses, high healthcare costs, and the presence of major companies. Furthermore, the medical device demand rises as a result of an increase in cardiopulmonary bypass procedures brought on by the rising prevalence of respiratory diseases like acute respiratory syndrome and chronic diseases like cardiovascular disease, coronary heart disease, and stroke in the general population. Thus the market is expanding as a result of businesses' increasing emphasis on creating cutting-edge goods and their adoption of diverse business tactics, such partnerships and acquisitions, to maintain their market positions.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to factors such as an aging population, rising per capita income, and increased health consciousness among the populace, the Asia Pacific area grew at the quickest rate throughout the projected period. Moreover, the rising investments in the region's healthcare infrastructure are expected to support the growth of the medical device market. China and India are two of the major nations in the Asia Pacific area, ranking second and fifth respectively in the world market for revenue. In these nations, healthcare reforms and incentives provided by local governments mostly control the medical device industry.
Some of the key players profiled in the Medical Device Market include: Stryker, Medtronic, Fresenius SE & Co. KGaA, Abbott, Cardinal Health, BD, Koninklijke Philips N.V., General Electric Company, Siemens Healthineers AG, 3M Company, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd, Smith & Nephew PLC, Braun Melsungen AG, Intuitive Surgical, Fujifilm, Canon Medical Systems, Alcon Laboratories, Edwards Lifesciences and Thermo Fisher
In November 2023, Fresenius Kabi announced the launch of its tocilizumab biosimilar Tyenne® referencing RoActemra®** (tocilizumab) in the European Union. Tyenne® becomes the first tocilizumab biosimilar available in Europe for the treatment of several inflammatory and immune diseases.
In September 2023, Medtronic plc in healthcare technology, announced CE (Conformite Europeenne) Mark approval for its new all-in-one, disposable Simplera™ continuous glucose monitor (CGM) featuring a simple, two-step insertion process.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.